Skip to main navigation
Skip to search
Skip to main content
Universidad de los Andes Home
English
Español
Search content at Universidad de los Andes
Home
Profiles
Research units
Research output
Projects
Press/Media
Activities
Equipment
Student theses
Prizes
Courses
Impacts
Insuficiencia hepática fulminante: Fulminant hepatic failure
Translated title of the contribution
:
Fulminant hepatic failure
Jaime Poniachik T.
*
,
Rodrigo Quera P.
, Andrea Lui G.
*
Corresponding author for this work
Clínica Universidad de los Andes
Research output
:
Contribution to journal
›
Article
›
peer-review
6
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Fulminant hepatic failure: Fulminant hepatic failure'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Fulminant Hepatic Failure
100%
Etiology
40%
Encephalopathy
40%
Illness
20%
Ischemia
20%
Virus
20%
Survival Rate
20%
Innovative Therapies
20%
Jaundice
20%
Early Treatment
20%
Liver Transplantation
20%
Prothrombin Time
20%
Wilson Disease
20%
Hepatocyte Injury
20%
Hemodynamic Abnormalities
20%
Hyperacute
20%
Cerebral Edema
20%
Massive Hepatic Necrosis
20%
Extracorporeal Liver Support
20%
Subacute Encephalopathy
20%
Acute Encephalopathy
20%
Spontaneous Recovery
20%
Support System
20%
Infection Treatment
20%
Prolonged Prothrombin Time
20%
Auxiliary Liver Transplantation
20%
Total Bilirubin
20%
Budd-Chiari Syndrome
20%
Hepatic Encephalopathy
20%
Medicine and Dentistry
Fulminant Hepatic Failure
100%
Brain Disease
60%
Prothrombin Time
40%
Liver Support
40%
Etiology
40%
Ischemia
20%
Infection
20%
Hemodynamic
20%
Survival Rate
20%
Jaundice
20%
Experimental Therapy
20%
Liver Transplantation
20%
Brain Edema
20%
Hepatocyte
20%
Budd-Chiari Syndrome
20%
Bilirubin
20%
Liver Graft
20%
Hepatic Encephalopathy
20%
Acute Brain Disease
20%
Necrosis
20%
Wilson's Disease
20%
Diseases
20%
Virus
20%
Pharmacology, Toxicology and Pharmaceutical Science
Fulminant Hepatic Failure
100%
Budd Chiari Syndrome
20%
Brain Edema
20%
Wilson's Disease
20%
Hepatic Encephalopathy
20%
Acute Brain Disease
20%